New Leaf Venture Management III, L.L.C. SC 13D/A Deciphera Pharmaceuticals, Inc.

EXHIBIT F

SCHEDULE OF TRANSACTIONS EFFECTED DURING THE LAST 60 DAYS

The following table sets forth all transactions with respect to Shares effected in the last sixty (60) days by the Reporting Persons or on behalf of the Reporting Persons in respect of the Shares. The table below includes all transactions through August 23, 2019. All such transactions were sales effected in the open market.

Transacting Entity	Trade Date	Buy/Sell	No. of Shares		Price per Share			Security
New Leaf Ventures III, L.P.	8/15/2019	Sell		71,550	$	36.0911	(1)	Common Stock
New Leaf Biopharma Opportunities I, L.P.	8/15/2019	Sell		78,450	$	36.0911	(1)	Common Stock
New Leaf Ventures III, L.P.	8/16/2019	Sell		95,400	$	36.6423	(2)	Common Stock
New Leaf Biopharma Opportunities I, L.P.	8/16/2019	Sell		104,600	$	36.6423	(2)	Common Stock
New Leaf Ventures III, L.P.	8/20/2019	Sell		35,775	$	36.8630	(3)	Common Stock
New Leaf Biopharma Opportunities I, L.P.	8/20/2019	Sell		39,225	$	36.8630	(3)	Common Stock
New Leaf Ventures III, L.P.	8/22/2019	Sell		40,047	$	36.8513	(4)	Common Stock
New Leaf Biopharma Opportunities I, L.P.	8/22/2019	Sell		43,910	$	36.8513	(4)	Common Stock
New Leaf Ventures III, L.P.	8/23/2019	Sell		11,174	$	37.3035	(5)	Common Stock
New Leaf Biopharma Opportunities I, L.P.	8/23/2019	Sell		12,252	$	37.3035	(5)	Common Stock

⁽¹⁾  The price reported in the Price per Share column is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $36.00 to $36.64, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 1.

⁽²⁾  The price reported in the Price per Share column is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $36.00 to $37.32, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 2.

⁽³⁾  The price reported in the Price per Share column is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $36.01 to $37.00, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 3.

⁽⁴⁾  The price reported in the Price per Share column is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $36.30 to $37.74, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 4.

⁽⁵⁾  The price reported in the Price per Share column is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $37.25 to $37.44, inclusive. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote 5.